EGFR and head and neck squamous cell carcinoma: In addition, it has been reported that IL-6 autocrine activates STAT3 in an EGFR-independent manner and contribute to HNSCC cells proliferation [42], however, we found that IL-6 level was not changed in EGF-treated cells.